JASPER THERAPEUTICS, INC. Shares Authorized
JASPER THERAPEUTICS, INC. (JSPR) had Shares Authorized of 492.00 million shares as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesAuthorized · last filed 2026-08-14
- 2026-06-30: Common Stock, Shares Authorized 492.00M shares.
- 2026-03-31: Common Stock, Shares Authorized 492.00M shares.
- 2025-12-31: Common Stock, Shares Authorized 492.00M shares.
- 2025-09-30: Common Stock, Shares Authorized 492.00M shares.
| Period end | Common Stock, Shares Authorized |
|---|---|
| 2026-06-30 | 492.00M shares 10-Q · filed 2026-08-14 |
| 2026-03-31 | 492.00M shares 10-Q · filed 2026-05-14 |
| 2025-12-31 | 492.00M shares 10-Q · filed 2026-08-14 |
| 2025-09-30 | 492.00M shares 10-Q · filed 2025-11-10 |
| 2025-06-30 | 492.00M shares 10-Q · filed 2025-08-13 |
| 2025-03-31 | 492.00M shares 10-Q · filed 2025-05-12 |
| 2024-12-31 | 492.00M shares 10-K · filed 2026-03-30 |
| 2024-09-30 | 492.00M shares 10-Q · filed 2024-11-07 |
| 2024-06-30 | 492.00M shares 10-Q · filed 2024-08-13 |
| 2024-03-31 | 492.00M shares 10-Q · filed 2024-05-14 |
| 2023-12-31 | 492.00M shares 10-K · filed 2025-02-28 |
| 2023-09-30 | 492.00M shares 10-Q · filed 2023-11-09 |
| 2023-06-30 | 492.00M shares 10-Q · filed 2023-08-11 |
| 2023-03-31 | 492.00M shares 10-Q · filed 2023-05-12 |
| 2022-12-31 | 492.00M shares 10-K · filed 2024-03-05 |
| 2022-09-30 | 492.00M shares 10-Q · filed 2022-11-10 |
| 2022-06-30 | 492.00M shares 10-Q · filed 2022-08-12 |
| 2022-03-31 | 492.00M shares 10-Q · filed 2022-05-12 |
| 2021-12-31 | 492.00M shares 10-K · filed 2023-03-08 |
| 2021-09-30 | 492.00M shares 10-Q · filed 2021-11-12 |
| 2020-12-31 | 50.22M shares 10-K · filed 2022-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |